Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,994 | 307 | 51.2% |
| Consulting Fee | $9,078 | 3 | 33.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,684 | 2 | 6.2% |
| Travel and Lodging | $1,581 | 4 | 5.8% |
| Education | $690.81 | 11 | 2.5% |
| Honoraria | $300.00 | 1 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Edwards Lifesciences Corporation | $11,198 | 24 | $0 (2024) |
| Abbott Laboratories | $2,541 | 25 | $0 (2024) |
| BIOTRONIK INC. | $2,431 | 24 | $0 (2024) |
| Amgen Inc. | $2,176 | 40 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,150 | 37 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $873.80 | 12 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $862.29 | 38 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $782.60 | 6 | $0 (2019) |
| Medtronic Vascular, Inc. | $600.66 | 3 | $0 (2019) |
| Boston Scientific Corporation | $572.18 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $13,613 | 60 | Edwards Lifesciences Corporation ($10,862) |
| 2023 | $1,597 | 44 | BIOTRONIK INC. ($271.59) |
| 2022 | $1,752 | 39 | Abbott Laboratories ($618.07) |
| 2021 | $1,540 | 45 | BIOTRONIK INC. ($456.61) |
| 2020 | $1,397 | 33 | Abbott Laboratories ($641.67) |
| 2019 | $2,852 | 36 | SANOFI-AVENTIS U.S. LLC ($646.42) |
| 2018 | $1,769 | 32 | BIOTRONIK INC. ($271.98) |
| 2017 | $2,808 | 39 | Abbott Laboratories ($665.40) |
All Payment Transactions
328 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $30.39 | General |
| Category: DIABETES | ||||||
| 12/19/2024 | Edwards Lifesciences Corporation | EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) | Consulting Fee | Cash or cash equivalent | $795.00 | General |
| Category: Transcatheter Heart Valves | ||||||
| 12/11/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $29.22 | General |
| Category: Immunology | ||||||
| 12/03/2024 | Abbott Laboratories | — | Food and Beverage | In-kind items and services | $149.54 | General |
| Category: Structural Heart | ||||||
| 11/16/2024 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $184.58 | General |
| 11/15/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: Cardiology | ||||||
| 11/14/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $25.76 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/04/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: EPILEPSY | ||||||
| 11/01/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/30/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/29/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $5.24 | General |
| 10/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: DIABETES | ||||||
| 10/17/2024 | Edwards Lifesciences Corporation | SAPIEN 3 Ultra RESILIA (Device) | Food and Beverage | In-kind items and services | $22.45 | General |
| Category: Transcatheter Heart Valves | ||||||
| 10/16/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $24.70 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/10/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/09/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: Diabetes | ||||||
| 09/30/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $28.41 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/27/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/25/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Cardiology | ||||||
| 09/20/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/12/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $21.93 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/04/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $27.40 | General |
| Category: Diabetes | ||||||
| 08/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $32.68 | General |
| Category: DIABETES | ||||||
| 08/08/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/07/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $29.28 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,276 | 2,022 | $301,428 | $90,889 |
| 2022 | 17 | 1,120 | 1,414 | $479,890 | $133,649 |
| 2021 | 11 | 831 | 1,063 | $409,557 | $105,041 |
| 2020 | 18 | 1,294 | 1,862 | $521,644 | $152,673 |
All Medicare Procedures & Services
73 procedure records from CMS Medicare Utilization — Page 3 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93016 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision | Facility | 2021 | 26 | 26 | $1,613 | $523.12 | 32.4% |
| 93228 | Heart rhythm tracing, computer analysis, and interpretation of patient-triggered events greater than 24-hour ekg up to 30 days | Office | 2021 | 19 | 19 | $6,650 | $405.76 | 6.1% |
| 93018 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report | Facility | 2021 | 26 | 26 | $1,067 | $346.58 | 32.5% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 19 | 21 | $1,050 | $264.99 | 25.2% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Office | 2020 | 351 | 355 | $328,543 | $67,197 | 20.5% |
| 93229 | Heart rhythm tracing, computer analysis, physician prescribed transmission of patient-triggered events greater than 24-hour ekg up to 30 days | Office | 2020 | 64 | 64 | $56,250 | $43,236 | 76.9% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Facility | 2020 | 110 | 124 | $25,788 | $7,486 | 29.0% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 461 | 940 | $22,560 | $7,168 | 31.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 31 | 74 | $9,250 | $4,726 | 51.1% |
| 93880 | Ultrasound scanning of blood flow (outside the brain) on both sides of head and neck | Office | 2020 | 19 | 20 | $9,000 | $3,872 | 43.0% |
| 93925 | Ultrasound study of arteries and arterial grafts of both legs | Office | 2020 | 16 | 16 | $6,400 | $3,593 | 56.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 32 | 42 | $9,526 | $3,024 | 31.7% |
| 93351 | Ultrasound examination and continuous monitoring of the heart performed during rest, exercise, and/or drug-induced stress with interpretation and report | Office | 2020 | 13 | 13 | $6,500 | $2,947 | 45.3% |
| 93970 | Ultrasound scan of veins of both arms or legs including assessment of compression and functional maneuvers | Office | 2020 | 15 | 15 | $8,250 | $2,718 | 32.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 16 | 29 | $6,003 | $1,938 | 32.3% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 12 | 14 | $4,150 | $1,356 | 32.7% |
| 93228 | Heart rhythm tracing, computer analysis, and interpretation of patient-triggered events greater than 24-hour ekg up to 30 days | Office | 2020 | 64 | 64 | $22,000 | $1,320 | 6.0% |
| 93320 | Doppler ultrasound study of heart blood flow, valves, and chambers | Office | 2020 | 13 | 13 | $1,690 | $671.97 | 39.8% |
| 93308 | Follow-up or limited ultrasound examination of heart | Facility | 2020 | 17 | 18 | $1,314 | $402.65 | 30.6% |
| 93325 | Doppler ultrasound study of color-directed heart blood flow, rate, and valve function | Office | 2020 | 13 | 13 | $1,950 | $313.77 | 16.1% |
| 93016 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision | Facility | 2020 | 14 | 14 | $882.00 | $266.16 | 30.2% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 19 | 20 | $1,000 | $262.74 | 26.3% |
| 93018 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report | Facility | 2020 | 14 | 14 | $588.00 | $176.63 | 30.0% |
About Dr. Savi Mushiyev, MD
Dr. Savi Mushiyev, MD is a Cardiovascular Disease healthcare provider based in Forest Hills, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/01/2008. The National Provider Identifier (NPI) number assigned to this provider is 1013179050.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Savi Mushiyev, MD has received a total of $27,328 in payments from pharmaceutical and medical device companies, with $13,613 received in 2024. These payments were reported across 328 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($13,994).
As a Medicare-enrolled provider, Mushiyev has provided services to 4,521 Medicare beneficiaries, totaling 6,361 services with total Medicare billing of $482,253. Data is available for 4 years (2020–2023), covering 73 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Location Forest Hills, NY
- Active Since 07/01/2008
- Last Updated 12/07/2009
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1013179050
Products in Payments
- EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) $8,745
- Repatha (Biological) $2,066
- XARELTO (Drug) $1,150
- ENTRESTO (Drug) $710.41
- JARDIANCE (Drug) $499.07
- BIOMONITOR (Device) $451.29
- ELIQUIS (Drug) $441.70
- MULTAQ (Drug) $421.78
- VERQUVO (Drug) $416.00
- Edora (Device) $383.98
- PRADAXA (Drug) $374.73
- BioMonitor 2 (Device) $363.38
- FORTIFY ASSURA (Device) $317.48
- Product in Development (Device) $300.00
- VALTOCO (Drug) $300.00
- SAPIEN 3 Ultra RESILIA (Device) $275.74
- Mitra Clip system (Device) $261.46
- PRALUENT (Drug) $238.89
- Fortify Assura, Ellipse ICD (Device) $186.62
- Assurity Pacemaker (Device) $186.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Forest Hills
Robert Rahmani, D.o, D.O
Cardiovascular Disease — Payments: $31,456
Dr. Mikhail Kapchits, M.d, M.D
Cardiovascular Disease — Payments: $17,112
Dr. Ronny Cohen
Cardiovascular Disease — Payments: $10,998
Dr. Sepideh Nabatian, Md, MD
Cardiovascular Disease — Payments: $9,213
Dr. Faraidoon Golyan, Do, DO
Cardiovascular Disease — Payments: $7,499
Dr. Sahadeo Ramnauth, Md, MD
Cardiovascular Disease — Payments: $2,588